2021 Update
Clinical Research Currents has temporarily suspended publication.
Learn about our new clinical trials startup, Sparrow Search, connecting patients with clinical trials.
Until recently, analyzing the amount of information generated in a clinical trial required labor-intensive, resource-consuming effort. A new advance in clinical development is the use of artificial intelligence (AI)-informed virtual assistants that allow us to “speak” to our data and get rapid insights, which allows us to correct our course before trial delays occur. (Clinical Leader)
Verily, the life sciences company owned by Google parent Alphabet, has partnered with Novartis, Sanofi, Otsuka, and Pfizer on a project that aims to speed up clinical trials. The pharma companies will use Verily’s clinical research tools- known as Project Baseline – to try to improve the recruitment of patients into clinical trials and make studies faster and more efficient. (pharmaforum)
In a recent survey, about one-third of clinical research professionals said that the technology systems they use are not intuitive or easy to access, and two-thirds said that automated sharing between systems is not reducing duplicate data entry. Fewer than half agreed that their organization has a training program that sets them up for success. (ACRP)
Improving clinical monitor and coordinator training was a hot topic at the recent ACRP 2019 conference. The clinical trial professional of the future will need the skills to deal with increasingly complex protocols and ever-evolving technologies. According to one speaker, “In 18 months, half of what we know now will be irrelevant.” (CenterWatch)
With the recent marriage between technology and science aimed at innovating aspects of clinical trials panels composed of experts from fields outside of pharma could prove to be impactful.(outsourcing-pharma.com)
A number of global ‘mega-trends’, such as dated technology and manufacturing inefficiencies, present major challenges for the drug industry, according to Dave Tudor. (BioPharma-Reporter.com)
www.appliedclinicaltrialsonline.com
Blockchain technology- a decentralized and encrypted way of distributing, sharing, and storing information – has the capability to transform the clinical research industry by providing a safe way to collect, store, and make accessible patient data. It could help to streamline communication between doctors and patients during a trial, increase patient engagement, and improve patient recruitment and retention. (Applied Clinical Trials)
The clinical trial market’s massive size makes it an attractive opportunity for innovation. This article lists startups using technology to address problems in the clinical study process, including improving clinical study design, matching patients with clinical trials, improving the clinical trial enrollment process, and reducing dropout rates. (mobihealthnews)
Blockchain provides real-time visibility into the entire clinical trial supply chain and has the potential to solve several of the industry’s biggest challenges. (outsourcing-pharma.com)
According to a new report by Deloitte, blockchain may be the key to accelerating clinical research. Large volumes of high-quality patient data are essential for healthcare researchers to make new discoveries, but the industry is experiencing challenges when attempting to collect and leverage big data. Blockchain could provide a solution to these issues, due to its potential to streamline data sharing and enhance interoperability. (HEALTH IT ANALYTICS)